切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2015, Vol. 11 ›› Issue (05) : 584 -588. doi: 10.3877/cma.j.issn.1673-5250.2015.05.007

所属专题: 文献

论著

不同促性腺激素进行控制性超促排卵的临床结局比较
黄夏曼1, 顾方乐1, 吕芳1, 潘宇1, 张晓梅1,*,*()   
  1. 1. 225001 扬州大学临床医学院生殖医学中心
  • 收稿日期:2015-06-12 修回日期:2015-08-09 出版日期:2015-10-01
  • 通信作者: 张晓梅

Comparison of clinical outcomes of controlled ovarian stimulation with different gonadotropin

Xiaman Huang1, Fangle Gu1, Fang Lyu1, Yu Pan1, Xiaomei Zhang1()   

  1. 1. Reproductive Medicine Center of Clinical Medical School of Yangzhou University, Yangzhou 225001, Jiangsu Province, China
  • Received:2015-06-12 Revised:2015-08-09 Published:2015-10-01
  • Corresponding author: Xiaomei Zhang
  • About author:
    Corresponding author: Zhang Xiaomei, Email:
引用本文:

黄夏曼, 顾方乐, 吕芳, 潘宇, 张晓梅. 不同促性腺激素进行控制性超促排卵的临床结局比较[J]. 中华妇幼临床医学杂志(电子版), 2015, 11(05): 584-588.

Xiaman Huang, Fangle Gu, Fang Lyu, Yu Pan, Xiaomei Zhang. Comparison of clinical outcomes of controlled ovarian stimulation with different gonadotropin[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2015, 11(05): 584-588.

目的

探讨不同促性腺激素(Gn)[重组人促卵泡激素(rFSH)与尿源性卵泡刺激素(uFSH)]进行控制性超促排卵(COH)临床结局的差异。

方法

选择2011年1月至2013年12月于扬州大学临床医学院生殖医学中心进行体外受精/卵胞浆内单精子注射-胚胎移植(IVF/ICSI-ET)助孕的396例患者共计428个周期为研究对象。按使用Gn药物的不同,将其分为rFSH组(253个周期)和uFSH组(175个周期)。比较两组患者一般情况、Gn用量、Gn使用天数、获卵数、优质卵泡数、种植率、不良结局发生率、妊娠率、活产率、自然流产率、多胎妊娠率以及卵巢刺激综合征(OHSS)发生率。两组患者年龄、体质指数(BMI)及不孕年限等一般临床病历资料比较,差异均无统计学意义(P>0.05)。

结果

①两组患者不孕因素中男方因素比较,差异有统计学意义(χ2=10.322;P<0.05)。而两组患者年龄、BMI、不孕年限、不孕类型、不孕原因中子宫内膜异位症、多囊卵巢综合征(PCOS)、不明原因不孕等方面比较,差异均无统计学意义(P>0.05)。②rFSH组和uFSH组Gn使用天数[(9.4±1.7)d vs (9.8±2.2) d]、Gn用量[(1 883.5±532.3) U vs (2 277.1±694.2) U]、获卵数[(12.3±6.1)个vs (10.1±5.4)个]、优质卵泡数[(9.1±5.2)个vs (7.8±4.9)个]、不良周期结局(9.1% vs 25.1%)、注射hCG日孕酮水平[(3.7±2.1)U/L vs (2.8±1.6) U/L]、活产率(69.7% vs 50.0%)比较,差异均有统计学意义(χ2=2.154,6.227,3.564,2.373,20.187,3.488,0.033;P<0.05)。

结论

rFSH所需Gn总剂量少,刺激周期短,改善了卵母细胞的数量和质量,并能减少不良结局发生率,最终获得更高的活产率。

Objective

To investigate differences in clinical outcomes of ovulation by different gonadotropin (Gn), including recombinant human follicle stimulating hormone (rFSH) and urinary FSH (uFSH).

Methods

A total of 396 cases of patients undergoing in vitro fertilization/intra-cytoplasmic sperm injection and embryo transfer (IVF/ICSI-ET)in Reproductive Medicine Center of Clinical Medical School of Yangzhou University from January 2011 to December 2013, a total of 428 cycles were collected as the research object. According to different types of Gn, the patient were divided into rFSH group (253 cycles) and uFSH group (175 cycles). General data, Gn dosage, number of Gn days, number of oocytes, the number of high-quality eggs, implantation rate, the incidence of adverse outcomes, pregnancy, live birth rate, abortion rate, multiple pregnancies and the incidence of ovarian hyperstimulation syndrome(OHSS) between two groups were compared. There were no significant differences in age, body mass index (BMI), and other clinical data between two groups (P>0.05).

Results

①The comparison between two groups of patients infertility factors, the difference of male factor was statistically significant(χ2=10.322, P<0.05). There were no statistically significant difference between two groups in age, BMI, duration of infertility, infertility type, causes of infertility in endometriosis, polycystic ovary syndrome (PCOS), unexplained infertility, etc. (P>0.05). ②The difference in number of Gn days [(9.4±1.7) d vs (9.8±2.2) d], Gn dosage [(1 883.5±532.3) U vs (2 277.1±694.2) U], the number of oocytes [(12.3±6.1) vs (10.1±5.4)], the number of high-quality eggs [(9.1±5.2) vs (7.8±4.9)], the incidence of adverse outcomes (9.1% vs 25.1%), progesterone level of hCG day [(3.7±2.1) U / L vs (2.8±1.6) U / L], live birth rate (69.7% vs 50.0%) between two groups were statistically significant (χ2=2.154, 6.227, 3.564, 2.373, 20.187, 3.488, 0.033; P<0.05).

Conclusions

Using rFSH, the total dose of Gn is less required and period to stimulate is short, it also improvs the quantity and quality of oocytes, at the same time, it can reduce the rate of adverse outcomes, and get high live birth rate.

表1 两组患者一般情况比较(±s)
表2 两组不良周期结局比较[个(%)]
表3 两组促排卵情况比较(±s)
表4 两组临床结局比较[个(%)]
[1]
Al-Inany H, Aboulghar M, Mansour R, et al. Meta-analysis of recombinant versus urinary-derived FSH: an update[J]. Hum Reprod, 2003, 18(2):305-313.
[2]
蒋元华,段金良.丽申宝与果纳芬在IVF-ET长方案的临床比较[J].中国性科学,2013, 22(1):29-31.
[3]
张娟,方小玲,谭小军,等. 果那芬和丽申宝在超促排卵治疗中的疗效比较[J].生殖医学杂志,2013, 22(1):62-64.
[4]
Fulghesu AM, Apa R, Belosi C, et al. Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment[J]. Horm Res, 2001, 55(5):224-228.
[5]
Streda R, Koryntová D, Mardesic T, et al. Clinical effects of recombinant versus urinary gonadotropins in ovulation induction [J]. Ceska Gynekol, 2011, 76(2):108-113.
[6]
Hugues JN, Bry-Gauillard H, Bständig B, et al. Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization-embryotransfer [J]. J Assist Reprod Genet, 2001, 18(4):191-196.
[7]
Loumaye E, Dreano M, Galazka, et al. Recombinant follicle stimulating hormone: development of the first biotechnology product for the treatment of infertility [J]. Hum Reprod Update, 1998, 4:862-881.
[8]
Daya S, Ledger W, Auray JP, et al. Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK [J]. Hum Reprod, 2001, 16(12):2563-2569.
[9]
Balasch J, Barri PN. Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspective [J]. J Assist Reprod Genet, 2001, 18(2):45-55.
[10]
Sunkara SK, Rittenberg V, Raine-Fenning N, et al. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles[J]. Hum Reprod, 2011, 26(7):1768-1774.
[11]
Stoop D, Ermini B, Polyzos NP, et al. Reproductive potential of a metaphase Ⅱ oocyte retrieved after ovarian stimulation: an analysis of 23 354 ICSI cycles [J]. Hum Reprod, 2012, 27(7):2030-2035.
[12]
Macklon NS, Fauser BC. Mild stimulation in in vitro fertilization [J]. Ann NY Acad Sci, 2003, 997:105-111.
[13]
Pellicer A, Ballester MJ. Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels [J]. Hum Reprod, 1994, 9(5):806-811.
[14]
Liu X, Hao C, Wang J. Efficacy of highly purified urinary FSH versus recombinant FSH in chinese women over 37 years undergoing assisted reproductive techniques [J]. Int J Fertil Steril, 2015, 8(4):385-392.
[15]
Mochtar MH, Van der Veen, Ziech M, et al. Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles [J]. Cochrane Database Syst Rev, 2007, 18(2):CD005070-CD005070.
[16]
Matorras R, Prieto B, Exposito A, et al. Mid-follicular LH supplementation in women aged 35-39 years undergoing ICSI cycles: a randomized controlled study [J]. Reprod Biomed Online, 2009, 19(6):879-887.
[17]
Hillier SG. Paracrine support of ovarian stimulation [J]. Mol Hum Reprod, 2009, 15(12):843-850.
[1] 顾娟, 孙擎擎, 胡方方, 曹义娟, 祁玉娟. 子宫内膜容受性检测改善胚胎反复种植失败患者妊娠结局的临床应用[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 582-587.
[2] 欧阳振波, 魏世远, 盘翠丽, 高天旸, 钟碧婷, 许姣姣, 吴嘉雯. 人子宫移植后临床妊娠并成功分娩活产儿案例分析[J]. 中华妇幼临床医学杂志(电子版), 2020, 16(01): 93-99.
[3] 秦朗, 赵福敏, 陈娇, 罗红, 杨帆, 田雨, 庞厚清, 何敏, 徐红, 唐英, 叶璐. 产前经腹胎儿超声诊断体外受精-胚胎移植胎儿鼻骨发育异常的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2019, 15(04): 389-395.
[4] 于鲁华, 刘琳, 潘宇, 吕晓芹, 何笑, 王力, 张晓梅. 女方年龄及血清基础卵泡刺激素水平对夫精人工授精妊娠结局的影响[J]. 中华妇幼临床医学杂志(电子版), 2019, 15(02): 186-191.
[5] 孙擎擎, 曹义娟, 顾娟, 祁玉娟, 尹倩倩. 输卵管积水所致不孕症临床治疗分析[J]. 中华妇幼临床医学杂志(电子版), 2019, 15(01): 81-85.
[6] 马玲, 陈雅, 洪志丹, 周春. 卵泡输出率对不孕患者卵巢反应性及妊娠结局的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2018, 14(06): 704-710.
[7] 张璨, 胡艳秋, 佘宏, 陈芳. 延时摄像系统对胚胎发育及妊娠结局的影响[J]. 中华妇幼临床医学杂志(电子版), 2018, 14(06): 675-682.
[8] 魏丽娜, 张俊博, 赵考考, 孙秀芹. 不同治疗方案在体外受精-胚胎移植患者中的临床疗效比较[J]. 中华妇幼临床医学杂志(电子版), 2018, 14(03): 317-323.
[9] 庄虔莹, 李丽, 王文静, 康晓迪, 王素萍. 乙型肝炎病毒对体外受精-胚胎移植患者妊娠结局的影响[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(06): 426-430.
[10] 梁毓, 辛志敏, 兰永连, 李颖, 王树玉. 不孕夫妇非活动性乙型肝炎病毒表面抗原携带对体外受精-胚胎移植的影响[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(03): 171-176.
[11] 王丁然, 迟洪滨. 自身免疫甲状腺炎对子宫内膜异位症患者胚胎移植结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(06): 682-688.
[12] 吴利萍, 杜宁宁, 蒋静, 刘晶晶, 邢琼, 曹云霞. 自然周期冻融胚胎移植对辅助生殖技术下妊娠结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(01): 54-57.
[13] 路红琴, 何玉洁. 血清及卵泡液中25-羟维生素D与体外受精-胚胎移植妊娠结局的相关性[J]. 中华临床医师杂志(电子版), 2020, 14(06): 407-412.
[14] 孙绪磊, 徐嘉君, 冷义福, 文江, 张学奎, 卜英波, 马小菊, 胡淑敏. 弱畸形精子症与体外受精受精率和胚胎发育的相关性分析[J]. 中华临床医师杂志(电子版), 2017, 11(13): 1978-1981.
[15] 李福侠, 范华蕊, 胡桂钰, 盛燕. 注射绒毛膜促性腺激素日血清促黄体生成素水平对妊娠结局的影响[J]. 中华诊断学电子杂志, 2019, 07(02): 124-128.
阅读次数
全文


摘要